Name: | Tetrahydrocannabinol |
---|---|
PubChem Compound ID: | 11012622 |
Description: | A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC. |
Molecular formula: | C21H30O2 |
Molecular weight: | 319.493 g/mol |
Name: | Tetrahydrocannabinol |
---|---|
Name (isomeric): | DB00470 |
Drug Type: | small molecule |
Description: | A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC. |
Brand: | delta-9-tetrahydrocannabinol, Δ9-tetrahydrocannabinol, Dronabinol, Dea No. 7369, Marinol, Dea No. 7370, Δ9-THC, Abbott 40566, Dronabinolum [Latin], delta-9-THC, Dronabinol [Usan:Inn], Deltanyne |
Category: | Analgesics, Non-Narcotic, Psychotropic Drugs, Hallucinogens, Antiemetics, Analgesics |
CAS number: | 1972-08-3 |
Indication: | For the treatment of anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments |
---|---|
Pharmacology: | Marinol may has complex effects on the central nervous system (CNS), including cannabinoid receptors. Dronabinol may inhibit endorphins in the emetic center, suppress prostaglandin synthesis, and/or inhibit medullary activity through an unspecified cortical action. |
Mechanism of Action: |
The mechanism of action of marinol is not completely understood. It is thought that cannabinoid receptors in neural tissues may mediate the effects of dronabinol and other cannabinoids. Animal studies with other cannabinoids suggest that marinol's antiemetic effects may be due to inhibition of the vomiting control mechanism in the medulla oblongata...
show more » |
Absorption: | 90 - 95% |
Protein binding: | 97% |
Biotransformation: | Hepatic |
Route of elimination: | Dronabinol and its biotransformation products are excreted in both feces and urine. |
Half Life: | Alpha phase: approximately 4 hours; Beta phase: 25-36 hours |
Clearance: | 0.2 L/kg-hr |
Affected organisms: | Humans and other mammals |
Food interaction: |
| ||||
---|---|---|---|---|---|
Drug interaction: |
|